sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 10/02/2011
PIL Rifadin 150mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 30/11/2010 and displayed until 10/02/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/06/2009 and displayed until 30/11/2010
Reasons for adding or updating:
  • Company name change or merger
  • Change due to user-testing of patient information
Updated on 10/08/2006 and displayed until 08/06/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 21/06/2001 and displayed until 10/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   rifampicin